The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
A randomized controlled phase II study of the prophylactic effect of urea-based cream on the hand-foot skin reaction associated with sorafenib in advanced hepatocellular carcinoma.
Zhenggang Ren
No relevant relationships to disclose
Kangshun Zhu
No relevant relationships to disclose
Haiyan Kang
No relevant relationships to disclose
Minqiang Lu
No relevant relationships to disclose
Zengqiang Qu
No relevant relationships to disclose
Ligong Lu
No relevant relationships to disclose
Tianqiang Song
No relevant relationships to disclose
Weiping Zhou
No relevant relationships to disclose
Hui Wang
No relevant relationships to disclose
Weizhu Yang
No relevant relationships to disclose
Xuan Wang
No relevant relationships to disclose
Yongping Yang
No relevant relationships to disclose
Lehua Shi
No relevant relationships to disclose
Yuxian Bai
No relevant relationships to disclose
Sheng-Long Ye
Research Funding - Bayer